Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan

• Autori principali: Junko Terada-Hirashima (Autore), Yuki Takamatsu (Autore), Yosuke Shimizu (Autore), Yukari Uemura (Autore), Junko S. Takeuchi (Autore), Noriko Tomita (Autore), Kouki Matsuda (Autore), Kenji Maeda (Autore), Shohei Yamamoto (Autore), Ami Fukunaga (Autore), Norio Ohmagari (Autore), Ayako Mikami (Autore), Kengo Sonoda (Autore), Mugen Ujiie (Autore), Hiroaki Mitsuya (Autore), Wataru Sugiura (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Although vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) induce effective immune responses, vaccination with booster doses is necessary because of waning immunity. We conducted an open-label, non-randomized, single-arm study in adults in Japan to ass...